- Mutated EGFR-IN-1
-
- $0.00 / 1kg
-
2025-04-04
- CAS:1421372-66-8
- Min. Order: 1kg
- Purity: 98%
- Supply Ability: 1Ton
- Mutated EGFR-IN-1
-
- $82.00 / 100mg
-
2024-11-19
- CAS:1421372-66-8
- Min. Order:
- Purity: 99.73%
- Supply Ability: 10g
- Mutated EGFR-IN-1
-
- $5.00 / 1KG
-
2024-04-09
- CAS:1421372-66-8
- Min. Order: 1KG
- Purity: 98%
- Supply Ability: g-kg-tons, free sample is available
|
| Mutated EGFR-IN-1 Basic information |
Product Name: | Mutated EGFR-IN-1 | Synonyms: | Mutated EGFR-IN-1;HY-78869;AZD9291DA HCl salt;N1-[2-(diMethylaMino)ethyl]-5-Methoxy-N1-Methyl-N4-[4-(1-Methyl-1H-indol-3-yl)-2-pyriMidinyl]benzene-1,2,4-triamine;AZD9291 int-5;N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine;1,2,4-Benzenetriamine, N1-[2-(dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-;AZD9291 3 | CAS: | 1421372-66-8 | MF: | C25H31N7O | MW: | 445.56 | EINECS: | | Product Categories: | AZD9291;Pharmaceutical intermediate;API | Mol File: | 1421372-66-8.mol |  |
| Mutated EGFR-IN-1 Chemical Properties |
Boiling point | 676.5±65.0 °C(Predicted) | density | 1.21±0.1 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO: ≥ 75 mg/mL (168.33 mM) | pka | 9.07±0.28(Predicted) | form | Powder | InChIKey | HTNTZPBKKCORTP-UHFFFAOYSA-N | SMILES | C1(N(CCN(C)C)C)=CC(OC)=C(NC2=NC=CC(C3C4=C(N(C)C=3)C=CC=C4)=N2)C=C1N |
| Mutated EGFR-IN-1 Usage And Synthesis |
Uses | N1-?[2-?(Dimethylamino)?ethyl]?-?5-?methoxy-?N1-?methyl-?N4-?[4-?(1-?methyl-?1H-?indol-?3-?yl)?-?2-?pyrimidinyl]?-?1,?2,?4-?benzenetriamine can be involved as reactant/reagent in "Schizophrenic" self-assembly of dual thermoresponsive block copolymers bearing a zwitterionic and a non-ionic hydrophilic block. | IC 50 | EGFRL858R; EGFRExon 19 deletion/T790M; EGFRT790M |
| Mutated EGFR-IN-1 Preparation Products And Raw materials |
|